New evidence compares micro-ultrasound and MRI fusion biopsy for detecting clinically significant prostate cancer. Find out ...
The BiPASS trial evaluates Illuccix and Gozellix for prostate cancer detection, aiming to improve diagnostic accuracy and reduce biopsy necessity. Combining MRI with 68Ga-PSMA-11 PET imaging may ...
Introduction: The BIOPSTAGE trial investigates the added diagnostic value of combining prostate-specific membrane antigen positron emission tomography (PSMA PET) with multiparametric MRI (mpMRI) for ...
ABSTRACT: Introduction: Prostate cancer (PC) is a malignant proliferation of prostate cells. Common screening methods, such as digital rectal examination and prostate-specific antigen (PSA) testing, ...
Purpose: The accurate diagnosis of prostate cancer (PCa) remains challenging, particularly because standard biopsy techniques do not routinely include anterior zone, leading to potential missed ...
Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...
Dr. Aytekin Oto discussed Prostate MRI 101, noting that prostate MRI has evolved significantly since its first publication in 1982, with multiparametric MRI now embraced worldwide. With regards to ...
Laura and Andrew, pictured on a holiday to Naxos, decided to book an appointment with Prof Mark Emberton to make further sense of Andrew’s results I was worried by the results of my husband’s prostate ...
Veeru Kasivisvanathan, MBBS, BSc, FRCS, MSc, PGCert, PhD, highlighted how bpMRI aligns with evolving diagnostic strategies. In this video, Veeru Kasivisvanathan, MBBS ...
Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI. HealthDay News — Biparametric magnetic resonance imaging (MRI), which omits the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results